Dimensional Fund Advisors
TARS icon

Dimensional Fund Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Dimensional Fund Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-91,171
Closed -$5.42M – 3321
2025
Q3 		$5.42M Sell
91,171
-963
-1% -$47.4K ﹤0.01% 2523
2025
Q2 		$3.73M Sell
92,134
-216,096
-70% -$9.73M ﹤0.01% 2605
2025
Q1 		$15.8M Sell
308,230
-33,075
-10% -$1.63M ﹤0.01% 2052
2024
Q4 		$18.9M Sell
341,305
-62,658
-16% -$2.85M ﹤0.01% 2014
2024
Q3 		$13.3M Sell
403,963
-2,936
-0.7% -$82.5K ﹤0.01% 2178
2024
Q2 		$11.1M Sell
406,899
-17,931
-4% -$603K ﹤0.01% 2218
2024
Q1 		$15.4M Sell
424,830
-5,297
-1% -$156K ﹤0.01% 2117
2023
Q4 		$8.71M Buy
430,127
+74,444
+21% +$1.24M ﹤0.01% 2375
2023
Q3 		$6.32M Buy
355,683
+99,223
+39% +$1.76M ﹤0.01% 2451
2023
Q2 		$4.63M Buy
256,460
+20,930
+9% +$333K ﹤0.01% 2553
2023
Q1 		$2.96M Buy
+235,530
New +$3.44M ﹤0.01% 2635
2022
Q3 		$2.43M Buy
142,207
+29,232
+26% +$464K ﹤0.01% 2652
2022
Q2 		$1.65M Buy
112,975
+84,120
+292% +$1.26M ﹤0.01% 2797
2022
Q1 		$485K Buy
28,855
+19,865
+221% +$369K ﹤0.01% 3158
2021
Q4 		$202K Buy
+8,990
New +$234K ﹤0.01% 3342

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Dimensional Fund Advisors's TARS Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 91,171 shares — an estimated $5.42M sold.

Dimensional Fund Advisors first reported a position in TARS in Q4 2021 and held it in 15 quarters. The position peaked at $18.9M in Q4 2024. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 91,171 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $5.42M.
  • Dimensional Fund Advisors first reported a position in Tarsus Pharmaceuticals in Q4 2021 and held it in 15 quarters.
  • Dimensional Fund Advisors's Tarsus Pharmaceuticals position peaked at $18.9M in Q4 2024.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.